aTyr Pharma, Inc. (ATYR)
0.5005
+0.01
(+1.52%)
USD |
NASDAQ |
Sep 03, 16:00
0.5005
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Price to Book Value : 1.006 for Sept. 3, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 02, 2026 | 0.9912 |
| September 01, 2026 | 0.958 |
| August 31, 2026 | 1.069 |
| August 28, 2026 | 1.086 |
| August 27, 2026 | 1.115 |
| August 26, 2026 | 1.108 |
| August 25, 2026 | 1.146 |
| August 24, 2026 | 1.066 |
| August 21, 2026 | 1.008 |
| August 20, 2026 | 1.011 |
| August 19, 2026 | 1.071 |
| August 18, 2026 | 1.014 |
| August 17, 2026 | 1.043 |
| August 14, 2026 | 1.124 |
| August 13, 2026 | 1.112 |
| August 12, 2026 | 1.086 |
| August 11, 2026 | 1.074 |
| August 10, 2026 | 1.063 |
| August 07, 2026 | 1.028 |
| August 06, 2026 | 1.009 |
| August 05, 2026 | 1.064 |
| August 04, 2026 | 1.064 |
| August 03, 2026 | 0.9892 |
| July 31, 2026 | 0.9765 |
| July 30, 2026 | 0.965 |
| Date | Value |
|---|---|
| July 29, 2026 | 0.9711 |
| July 28, 2026 | 0.9932 |
| July 27, 2026 | 0.9843 |
| July 24, 2026 | 0.9516 |
| July 23, 2026 | 1.001 |
| July 22, 2026 | 0.9791 |
| July 21, 2026 | 0.9769 |
| July 20, 2026 | 0.9779 |
| July 17, 2026 | 1.025 |
| July 16, 2026 | 1.037 |
| July 15, 2026 | 1.074 |
| July 14, 2026 | 0.9771 |
| July 13, 2026 | 1.014 |
| July 10, 2026 | 1.094 |
| July 09, 2026 | 1.170 |
| July 08, 2026 | 1.293 |
| July 07, 2026 | 1.219 |
| July 06, 2026 | 1.315 |
| July 02, 2026 | 1.191 |
| July 01, 2026 | 1.186 |
| June 30, 2026 | 1.200 |
| June 29, 2026 | 0.9586 |
| June 26, 2026 | 0.8928 |
| June 25, 2026 | 0.9473 |
| June 24, 2026 | 0.9503 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| MetaVia, Inc. | 1.774 |
| Alnylam Pharmaceuticals, Inc. | 26.09 |
| ACADIA Pharmaceuticals, Inc. | 3.670 |
| Anika Therapeutics, Inc. | 2.048 |
| Savara, Inc. | 7.664 |
Price to Book Value Related Metrics
| PS Ratio | 257.68 |
| Price | 0.5005 |
| Earnings Yield | -124.4% |
| Market Cap | 49.09M |